Table 2 Clinical features and laboratory results of non-AKI and AKI groups
Non-AKI group (n = 47) | AKI group (n = 11) | p value | |
|---|---|---|---|
At the time of admission | |||
Age (y) | 39.1 ± 17.7 | 33.4 ± 11.3 | 0.309 |
gender (M/F) | 39/8 | 7/4 | 0.154 |
TBSA (%) | 32.0 ± 10.1 | 44.2 ± 22.4a | 0.008 |
Third-degree burn area (%) | 5(0,14) | 27(9,48) | 0.000 |
Inhalation injury,n (%) | 6(12.8) | 7(63.6) | 0.000 |
Rhabdomyolysis,n (%) | 5(10.6) | 6(54.5) | 0.001 |
BUN (mmol/L) | 4.52 ± 1.14 | 7.02 ± 1.53 | 0.000 |
Scr (μmol/L) | 55.2 ± 14.1 | 85.3 ± 21.6 | 0.000 |
Urinary KIM-1 (ng/mL) | 4.23 ± 1.25 | 5.84 ± 1.89 | 0.001 |
Urinary IL-18 (pg/mL) | 6.15 ± 2.57 | 9.64 ± 2.43 | 0.000 |
APACHE II Score | 8.34 ± 5.84 | 16.3 ± 7.35a | 0.000 |
48 h after admission | |||
BUN (mmol/L) | 5.52 ± 1.45 | 11.4 ± 2.99 | 0.000 |
Scr (μmol/L) | 57.4 ± 15.0 | 178.4 ± 58.8 | 0.000 |
U KIM-1 (ng/mL) | 4.62 ± 1.25 | 6.18 ± 1.62 | 0.001 |
UIL-18 (pg/mL) | 5.80 ± 2.16 | 10.9 ± 2.86 | 0.000 |
Mechanical ventilation,n (%) | 0 | 5(45.5) | / |
CRRT,n (%) | 0 | 5(45.5) | / |
APACHE II Score | 8.36 ± 6.38 | 29.3 ± 7.77a | 0.000 |
Wihtin 4 weeks | |||
Mortality,n (%) | 0 | 4(36.4) | / |